Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

OBJECTIVE: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease globally, yet no therapies are approved. The effects of Escherichia coli Nissle 1917 expressing aldafermin, an engineered anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannone, Valeria, Babu, Ambrin Farizah, Lok, Johnson, Gómez-Gallego, Carlos, D'Auria, Giuseppe, Vazquez-Uribe, Ruben, Vaaben, Troels Holger, Bongers, Mareike, Mikkonen, Santtu, Vaittinen, Maija, Tikkanen, Ida, Kettunen, Mikko, Klåvus, Anton, Sehgal, Ratika, Kaminska, Dorota, Pihlajamaki, Jussi, Hanhineva, Kati, El-Nezami, Hani, Sommer, Morten Otto Alexander, Kolehmainen, Marjukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618820/
https://www.ncbi.nlm.nih.gov/pubmed/37839774
http://dx.doi.org/10.1016/j.molmet.2023.101823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618820/
https://www.ncbi.nlm.nih.gov/pubmed/37839774
http://dx.doi.org/10.1016/j.molmet.2023.101823

Ejemplares similares